The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus

Summary

Secretrol administered over a 6 month period to patients with Barrett's Esophagus will be safe and well tolerated. Further, pH control will be evaluated in the distal esophageal mucosa and just below the squamocolumnar junction.

Timeline

Start

2013-04

Primary completion

2015-04

Completion

—

Drugs

Indications